Interestingly, in animal models, it has already been established that BDNF can be the potential therapeutic target for psychiatric disorders and neurological disorders, even though the BDNF protein itself has a short half-life and can hardly penetrate the blood brain barrier [91,92,93]. Here, BDNF is linked to nervous system disorder.